{"id":517862,"date":"2021-07-27T02:03:03","date_gmt":"2021-07-27T06:03:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/"},"modified":"2021-07-27T02:03:03","modified_gmt":"2021-07-27T06:03:03","slug":"verona-pharma-announces-august-2021-virtual-investor-conference-participation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/","title":{"rendered":"Verona Pharma Announces August 2021 Virtual Investor Conference Participation"},"content":{"rendered":"
\n

LONDON and RALEIGH, N.C., July 27, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (\u201cVerona Pharma\u201d), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present at the following virtual investor conferences in August 2021:<\/p>\n

\n BTIG Virtual Biotechnology Conference <\/strong>
\n
Date: Monday, August 9
Time: 1:30 PM EDT \/ 6:30 PM BST<\/p>\n

\n 12th Annual Wedbush PacGrow Healthcare Virtual Conference <\/strong>
\n
Date: Wednesday, August 11
Time: 3:30 PM EDT \/ 8:30 PM BST
Panel: Breathless and Under Pressure \u2013 Innovative Inhaled Treatments For Respiratory Diseases<\/p>\n

\n 41st Annual Canaccord Genuity Growth Conference <\/strong>
\n
Date: Thursday, August 12
Time: 11:00 AM EDT \/ 4:00 PM BST<\/p>\n

A webcast of the Canaccord fireside chat will be available for 90 days on the Events and Presentations link on the Investors page of the Company\u2019s website, www.veronapharma.com<\/a>.<\/p>\n\n\n\n\n\n\n\n\n\n
\n Verona Pharma plc<\/strong>\n <\/td>\nUS Tel: +1-833-417-0262
UK Tel: +44 (0)203 283 4200<\/td>\n<\/tr>\n
Victoria Stewart, Director of Investor Relations and Communications<\/td>\n\n info@veronapharma.com<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Argot Partners<\/strong>
\n
(US Investor Enquiries)<\/td>\n		Tel: +1-212-600-1902
verona@argotpartners.com<\/a><\/td>\n<\/tr>\n
Kimberly Minarovich \/ Michael Barron<\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Optimum Strategic Communications<\/strong>
\n
(International Media and European Investor Enquiries)<\/td>\n		Tel: +44 (0)203 950 9144
verona@optimumcomms.com<\/a><\/td>\n<\/tr>\n
Mary Clark \/ Karl Hard \/ Elakiya Rangarajah<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

\n About Verona Pharma<\/strong>
\n \n <\/p>\n

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. If successfully developed and approved, Verona Pharma\u2019s product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. The Company is evaluating nebulized ensifentrine in its Phase 3 clinical program ENHANCE (\u201cEnsifentrine as a Novel inHAled Nebulized COPD thErapy\u201d) for COPD maintenance treatment. Two additional formulations of ensifentrine are in Phase 2 development for the treatment of COPD: dry powder inhaler (\u201cDPI\u201d) and pressurized metered-dose inhaler (\u201cpMDI\u201d). Ensifentrine has potential applications in cystic fibrosis, asthma and other respiratory diseases. For more information, please visit www.veronapharma.com<\/a>.<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON and RALEIGH, N.C., July 27, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (\u201cVerona Pharma\u201d), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present at the following virtual investor conferences in August 2021: BTIG Virtual Biotechnology Conference Date: Monday, August 9Time: 1:30 PM EDT \/ 6:30 PM BST 12th Annual Wedbush PacGrow Healthcare Virtual Conference Date: Wednesday, August 11Time: 3:30 PM EDT \/ 8:30 PM BSTPanel: Breathless and Under Pressure \u2013 Innovative Inhaled Treatments For Respiratory Diseases 41st Annual Canaccord Genuity Growth Conference Date: Thursday, August 12 Time: 11:00 AM EDT \/ 4:00 PM BST A webcast of the Canaccord fireside chat will be available for … <\/p>\n

Continue reading “Verona Pharma Announces August 2021 Virtual Investor Conference Participation”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-517862","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVerona Pharma Announces August 2021 Virtual Investor Conference Participation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verona Pharma Announces August 2021 Virtual Investor Conference Participation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON and RALEIGH, N.C., July 27, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (\u201cVerona Pharma\u201d), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present at the following virtual investor conferences in August 2021: BTIG Virtual Biotechnology Conference Date: Monday, August 9Time: 1:30 PM EDT \/ 6:30 PM BST 12th Annual Wedbush PacGrow Healthcare Virtual Conference Date: Wednesday, August 11Time: 3:30 PM EDT \/ 8:30 PM BSTPanel: Breathless and Under Pressure \u2013 Innovative Inhaled Treatments For Respiratory Diseases 41st Annual Canaccord Genuity Growth Conference Date: Thursday, August 12 Time: 11:00 AM EDT \/ 4:00 PM BST A webcast of the Canaccord fireside chat will be available for … Continue reading "Verona Pharma Announces August 2021 Virtual Investor Conference Participation"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-27T06:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Verona Pharma Announces August 2021 Virtual Investor Conference Participation\",\"datePublished\":\"2021-07-27T06:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/\"},\"wordCount\":319,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/\",\"name\":\"Verona Pharma Announces August 2021 Virtual Investor Conference Participation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=\",\"datePublished\":\"2021-07-27T06:03:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verona Pharma Announces August 2021 Virtual Investor Conference Participation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Verona Pharma Announces August 2021 Virtual Investor Conference Participation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/","og_locale":"en_US","og_type":"article","og_title":"Verona Pharma Announces August 2021 Virtual Investor Conference Participation - Market Newsdesk","og_description":"LONDON and RALEIGH, N.C., July 27, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (\u201cVerona Pharma\u201d), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present at the following virtual investor conferences in August 2021: BTIG Virtual Biotechnology Conference Date: Monday, August 9Time: 1:30 PM EDT \/ 6:30 PM BST 12th Annual Wedbush PacGrow Healthcare Virtual Conference Date: Wednesday, August 11Time: 3:30 PM EDT \/ 8:30 PM BSTPanel: Breathless and Under Pressure \u2013 Innovative Inhaled Treatments For Respiratory Diseases 41st Annual Canaccord Genuity Growth Conference Date: Thursday, August 12 Time: 11:00 AM EDT \/ 4:00 PM BST A webcast of the Canaccord fireside chat will be available for … Continue reading \"Verona Pharma Announces August 2021 Virtual Investor Conference Participation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-27T06:03:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Verona Pharma Announces August 2021 Virtual Investor Conference Participation","datePublished":"2021-07-27T06:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/"},"wordCount":319,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/","name":"Verona Pharma Announces August 2021 Virtual Investor Conference Participation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=","datePublished":"2021-07-27T06:03:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg2NyM0MzE0OTg1IzIwODQzNjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-announces-august-2021-virtual-investor-conference-participation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Verona Pharma Announces August 2021 Virtual Investor Conference Participation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=517862"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/517862\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=517862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=517862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=517862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}